"10.1371_journal.pone.0090761","plos one","2014-03-21T00:00:00Z","Erica B Schleifman; Rachel Tam; Rajesh Patel; Alison Tsan; Teiko Sumiyoshi; Ling Fu; Rupal Desai; Nancy Schoenbrunner; Thomas W Myers; Keith Bauer; Edward Smith; Rajiv Raja","Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America; Chemistry and Innovation Technology, Pleasanton, California, United States of America; Program in Core Research, Roche Molecular Systems Inc., Pleasanton, California, United States of America","Conceived and designed the experiments: RR RP. Performed the experiments: RT E. Schleifman RP RD. Analyzed the data: RP E. Schleifman RT TS. Contributed reagents/materials/analysis tools: RP AT RT RD LF NS TM KB E. Smith RR. Wrote the paper: E. Schleifman RT RP AT NS TM KB E. Smith RR.","The authors have read the journals policy and have the following conflicts: All studies were funded by Genentech, Inc. Erica Schleifman, Rachel Tam, Rajesh Patel, Teiko Sumiyoshi, Ling Fu, Rupal Desai, and Rajiv Raja are or were employed by Genentech, and Alison Tsan, Nancy Schoenbrunner, Thomas W. Myers, Keith Bauer, and Edward Smith are or were employed by Roche Molecular Systems Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Erica B Schleifman","EBS",12,TRUE,2,2,2,1,TRUE,TRUE,TRUE,1,"5",FALSE
